Answer
Tranylcypromine sulfate is excreted in human milk, and risk to the breastfed child cannot be excluded, so a decision is needed whether to discontinue breastfeeding or discontinue or abstain from treatment, considering breastfeeding benefits for the child and treatment benefits for the woman.
Sources for this answer
- Tranylcypromine 10 mg TabletsADVANZ Pharma · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked